Preclinical activity of trans-indazolium [tetrachlorobisindazoleruthenate(III)] (NSC 666158; IndCR; KP 1019) against tumour colony-forming units and haematopoietic progenitor cells
- 31 December 1997
- journal article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 33 (14), 2404-2410
- https://doi.org/10.1016/s0959-8049(97)00277-3
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Antineoplastic activity of three ruthenium derivatives against chemically induced colorectal carcinoma in ratsZeitschrift für Krebsforschung und Klinische Onkologie, 1992
- In vitro evaluation of platinum, titanium and ruthenium metal complexes in cisplatin-sensitive and-resistant rat ovarian tumorsCancer Chemotherapy and Pharmacology, 1991
- New tumor-inhibiting metal complexesCancer Treatment Reviews, 1990
- Metal Complexes as Antitumour AgentsPublished by Elsevier BV ,1990
- Ruthenium Chemistry Pertaining to the Design of Anticancer AgentsPublished by Springer Science and Business Media LLC ,1989
- Biphasic Effect of Vanadium Salts on In Vitro Tumor Colony GrowthThe International Journal of Cell Cloning, 1987
- The human tumor cloning assay in cancer research and therapy: A review with clinical correlationsCurrent Problems in Cancer, 1985
- Tumor stem cell cloning in agar-containing capillariesThe Science of Nature, 1981